Pulmonary-artery catheters--peace at last?
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to Deborah Shure.
Explore the source record for details and available documents.
Gender differences in pulmonary vascular diseases, as exemplified by primary pulmonary hypertension and scleroderma-related pulmonary hypertension, are not well-explained; however, in general terms, they seem to be related to a combination of genetic predispositions and gender-specific environmental triggers. More information is needed in both areas with respect to mechanisms of disease. More information also is needed about possible gender differences in disease presentation,course, and response to treatments.
Many risk factors for morbidity and mortality with lung resection have been identified. Factors such as age, gender, and cancer stage cannot be altered, but lung function can be optimized by treating COPD or asthma with bronchodilators, corticosteroids, or antibiotics (when indicated) and by inspiratory muscle training. Although smoking cessation 2 months in advance of surgery may not be feasible, cessation nevertheless should be encouraged because it may decrease postoperative inflammation and in the long-term may decrease the risk of recurrence. In addition, morbidity and mortality can be minimized by careful patient selection using lung scanning or CT to determine predicted postoperative functions (FEV1% and DLco%) and some form of exercise testing, such as cardiopulmonary exercise testing or simple stair climbing. When the risk of surgery is high, any benefit from possible cure must be weighed against the risk of long-term disability or death. Although much data are available to guide clinicians in these decisions, there still is no one test that provides the answer in individual cases. The art and science of medicine must merge at this point.